Combination benefit of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) and dexamethasone or indomethacin in adjuvant arthritic rats
- 1 August 1999
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 48 (8) , 453-460
- https://doi.org/10.1007/s000110050486
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: